Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details)

v3.22.2.2
Net Loss Per Share (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Option Indexed to Issuer's Equity [Line Items]        
Amount of weighted-average anti-dilutive common shares 5,865 3,641 6,561 2,247
Warrant [Member]        
Option Indexed to Issuer's Equity [Line Items]        
Amount of weighted-average anti-dilutive common shares 4,933 2,949 5,586 1,651
Share-Based Payment Arrangement, Option [Member]        
Option Indexed to Issuer's Equity [Line Items]        
Amount of weighted-average anti-dilutive common shares 932 692 975 596